StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Trimethylsilyl triflate → 1-(2,3,5-Tri-O-benzyl-beta-D-ribofuranosyl)-2,4,5,6-tetrachlorobenzimidazole

HRID 263886
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 263886
[N+](C1C=CC(C(O[C@@H:11]2[O:31][C@H:30]([CH2:32][O:33][CH2:34][C:35]3[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=3)[C@@H:21]([O:22][CH2:23][C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[C@H:12]2[O:13][CH2:14][C:15]2[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=2)=O)=CC=1)([O-])=O.[Cl:43][C:44]1[NH:45][C:46]2[C:52]([Cl:53])=[C:51]([Cl:54])[C:50]([Cl:55])=[CH:49][C:47]=2[N:48]=1.[Si](OS(C(F)(F)F)(=O)=O)(C)(C)C>C(Cl)Cl.CC#N.CCOC(C)=O>[CH2:14]([O:13][C@@H:12]1[C@H:21]([O:22][CH2:23][C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)[C@@H:30]([CH2:32][O:33][CH2:34][C:35]2[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=2)[O:31][C@H:11]1[N:48]1[C:47]2[CH:49]=[C:50]([Cl:55])[C:51]([Cl:54])=[C:52]([Cl:53])[C:46]=2[N:45]=[C:44]1[Cl:43])[C:15]1[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=1
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 3

HCID 65367Trimethylsilyl triflateHCID 156026611-O-p-nitrobenzoyl-2,3,5-tri-O-benzyl-beta-D-ribofuranoseHCID 178478312HCID 178478312, Verbindung

Produkt 1

HCID 228765561-(2,3,5-Tri-O-benzyl-beta-D-ribofuranosyl)-2,4,5,6-tetrachlorobenzimidazoleAusbeute 45 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 6342
Acetonitrile
Lösungsmittel
2×
HCID 6344DichloromethaneLösungsmittel
HCID 8857Ethyl AcetateLösungsmittel

Reaktionsbedingungen

Temperatur
75 °C

Versuchsvorschrift

For the preparation of 1-O-chloro-2,3,5-tri-O-benzyl-D-ribofuranose, HCl gas was allowed to pass through a solution of 1-O-p-nitrobenzoyl-2,3,5-tri-O-benzyl-β-D-ribofuranose (1.479 g, 2.6 mmol) in 10 mL of dry CH2Cl2 at 0° C. for 15 min. The resulting suspension was quickly filtered and the filtrate was evaporated. The residue was coevaporated with dry MeCN and then dissolved in 5 mL of dry MeCN for immediate use in the subsequent glycosylation reaction. To a mixture of 13 (0.512 g, 2 mmol) in 10 mL of dry MeCN, was added 0.5 mL (2 mmol) of BSA. The reaction mixture was stirred at 75° C. for 20 min. This solution was treated with the above MeCN solution of the blocked carbohydrate and 0.464 mL (2.4 mmol) of TMSOTf at 70° C. for 20 min. The reaction mixture was cooled and diluted with EtOAc (50 mL). The EtOAc solution was washed with sat. NaHCO3 solution (50 mL×2), sat. NaCl solution (50 mL), dried (Na2SO4), and evaporated. The residue was chromatographed on a silica column (1.9×38 cm, eluted with hexane, 10%, 15% EtOAc/hexane). Evaporation of fractions 30-37 (15 mL per fraction) gave 0.593 g (45%) of 91a as a colorless syrup. MS: (EI) m/e 658.0780 (2%, M+ =658.0774). 1H NMR (DMSO-d6): d 7.93 (s, 1, 7-H), 7.35, 6.92 (2×m, 15, 3×PhCH2), 5.99 (d, 1, 1'-H, J1'-2' =8.0 Hz), 4.72, 4.58, 4.35 (3×m, 9, 2'-H, 3'-H, 4'-H, and 3×PhCH2), 3.76 (dd, 1, 5'-H, J4'-5' =2.0 Hz, J5'-5' =11.0 Hz), 3.65 (dd, 1, 5"-H, J4'-5" =2.5 Hz). 13C NMR (DMSO-d6): d 142.00 (C2), 138.40 (C3a), 137.81, 137.44, 136.74 (3×PhCH2), 131.34 (C7a), 128.08, 128.03, 127.59, 127.40, 127.32, 127.28, 126.97 (3×PhCH2 and C4), 124.64, 122.52 (C5 and C6), 112.65 (C7), 87.46 (C1'), 83.03, 77.08, 74.92 (C2', C3', and C4'), 72.43, 71.44, 71.28 (3×PhCH2), 69.22 (C5').

Aufarbeitung

  1. filtrationThe resulting suspension was quickly filtered
  2. customthe filtrate was evaporated
  3. dissolutiondissolved in 5 mL of dry MeCN for immediate use in the subsequent glycosylation reaction
  4. additionwas added 0.5 mL (2 mmol) of BSA
  5. temperatureThe reaction mixture was cooled
  6. washThe EtOAc solution was washed with sat. NaHCO3 solution (50 mL×2), sat. NaCl solution (50 mL)
  7. dry with materialdried (Na2SO4)
  8. customevaporated
  9. customThe residue was chromatographed on a silica column (1.9×38 cm, eluted with hexane, 10%, 15% EtOAc/hexane)
  10. customEvaporation of fractions 30-37 (15 mL per fraction)

Quellen und Nachweise

ORD-Eintrag
ord-d2427de7b99540f3bdc34d591f922343
Quelldatensatz
uspto-grants-1997_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US05646125

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion